Furthermore, as a receptor tyrosine kinase, CD117 has exhibited the ability to drive chemoresistance and has tumor-initiating capacity via activation of Wnt/β-catenin-ATP-binding cassette G2 signaling in OC cell lines [39]. Here, KIT is linked to neoplasm.